Similar articles

• [Systemic lupus erythematosus with neurologic onset and secondary antiphospholipid syndrome. A Case Study].

  Dima-Cozma C, Pandele GI, Rezuş E, Constantinescu A, Mihailovici MS. Dima-Cozma C, et al. Rev Med Chir Soc Med Nat Iasi. 2005 Apr-Jun;109(2):254-8. Rev Med Chir Soc Med Nat Iasi. 2005. PMID: 16607781 Romanian.
• [Systemic lupus erythematosus].

  Takeuchi T. Takeuchi T. Ryoikibetsu Shokogun Shirizu. 2000;(31):417-21. Ryoikibetsu Shokogun Shirizu. 2000. PMID: 11269123 Review. Japanese. No abstract available.
• Treatment of systemic lupus erythematosus: a 2012 update.

  Merrill JT. Merrill JT. Bull NYU Hosp Jt Dis. 2012;70(3):172-6. Bull NYU Hosp Jt Dis. 2012. PMID: 23259624 Review. No abstract available.
• Antiphospholipid syndrome and systemic lupus erythematosus: are they separate entities or just clinical presentations on the same scale?

  Shoenfeld Y, Meroni PL, Toubi E. Shoenfeld Y, et al. Curr Opin Rheumatol. 2009 Sep;21(5):495-500. doi: 10.1097/BOR.0b013e32832effdd. Curr Opin Rheumatol. 2009. PMID: 19593144 Review.
• [The therapy of systemic lupus erythematosus].

  Hiepe F, Burmester GR. Hiepe F, et al. Dtsch Med Wochenschr. 1996 Sep 13;121(37):1129-33. doi: 10.1055/s-2007-1024021. Dtsch Med Wochenschr. 1996. PMID: 8925728 Review. German. No abstract available.